Tag Archives: ISP

Top 10 Performing Stocks To Buy For 2019

The Q3 2017 earnings report for large cap consumer electronics retail stock Best Buy Co Inc (NYSE: BBY) is scheduled before the market opens on Thursday (November 17th) as a technical chart shows shares still in an apparent uptrend albeit also appearing to have leveled off or be range bound since mid-August:

A long term performance chart shows shares of Best Buy Co all over the place, Aaron’s, Inc (NYSE: AAN) coming in flat for investors and hhgregg, Inc (NYSE: HGG) severely underperforming:

Top 10 Performing Stocks To Buy For 2019: Daxor Corporation(DXR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Logan Wallace]

    Daxor Co. (NYSEAMERICAN:DXR) saw a significant growth in short interest in the month of March. As of March 29th, there was short interest totalling 234,045 shares, a growth of 1,257.4% from the March 15th total of 17,242 shares. Based on an average daily trading volume, of 1,214,477 shares, the days-to-cover ratio is presently 0.2 days. Currently, 33.3% of the company’s shares are short sold.

Top 10 Performing Stocks To Buy For 2019: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After it was announced yesterday that the stock would be added to the S&P 600 index, shares in Vanda Pharmaceuticals (NASDAQ:VNDA) jumped on Wednesday and were up 10% at 2 p.m. EDT. 

  • [By Stephan Byrd]

    Media stories about Vanda Pharmaceuticals (NASDAQ:VNDA) have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vanda Pharmaceuticals earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave media coverage about the biopharmaceutical company an impact score of 46.3857713397213 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Top 10 Performing Stocks To Buy For 2019: Martin Midstream Partners L.P.(MMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    ONEOK (NYSE:OKE) has made several shrewd moves over the past few years, which have positioned it to grow its high-yielding dividend at a high rate. One of the latest is its recent deal to buy out Martin Midstream Partners’ (NASDAQ:MMLP) 20% interest in the West Texas LPG pipeline system. With full control of that pipeline, the company can more aggressively pursue expansion opportunities, which recently led it to secure a second project on the system that positions it for even more growth in the future.

  • [By Matthew DiLallo]

    Master limited partnerships (MLPs) Buckeye Partners (NYSE:BPL) and Martin Midstream Partners (NASDAQ:MMLP) currently yield a jaw-dropping 13.7% and 17.4%, respectively. Both payouts are well above the 8% average yield of MLPs held in the Alerian MLP Index, which is a clear sign that the market doesn’t believe in the long-term viability of these payouts. Their unsustainability is even more apparent when we look at the embarrassingly weak financial profiles currently backing these payouts, which is why investors should steer clear of these high-yield stocks.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Martin Midstream Partners (MMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Martin Midstream Partners (MMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Buy For 2019: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Halyard Health (NYSE:HYH) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26.

  • [By Logan Wallace]

    Principal Financial Group Inc. lifted its stake in Halyard Health (NYSE:HYH) by 2.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 232,419 shares of the medical instruments supplier’s stock after purchasing an additional 6,411 shares during the period. Principal Financial Group Inc. owned 0.49% of Halyard Health worth $10,710,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Renaissance Technologies LLC acquired a new position in Halyard Health (NYSE:HYH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,805 shares of the medical instruments supplier’s stock, valued at approximately $453,000.

Top 10 Performing Stocks To Buy For 2019: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.

Top 10 Performing Stocks To Buy For 2019: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Paul Ausick]

    GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Canadian National Railway (CNI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Neha Chamaria]

    Investing for really long periods of time, however, becomes easier if you bet on industry stalwarts that have consistently rewarded shareholders and possess strong growth catalysts to keep them going for years to come. I can think of four such “forever” stocks right now: Canadian National Railway (NYSE:CNI), Waste Management (NYSE:WM), Mastercard (NYSE:MA), and Visa (NYSE:V).

  • [By Motley Fool Staff]

    In this segment, Brendan Mathews — a member of the Stock Advisor research team, and the portfolio lead for Odyssey 2 and Supernova — talks about the lessons one can learn from the tale of Canadian National (NYSE:CNI), a Stock Advisor recommendation since 2008. One might expect a railroad company to be a steady, predictable performer, but its stock chart looks more like a roller coaster over that period. (And, as a bonus, they also chat a bit about the story of salesforce.com (NYSE:CRM), so stick around to the end.)

Top 10 Performing Stocks To Buy For 2019: Build-A-Bear Workshop, Inc.(BBW)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dollar Tree, Inc. (NASDAQ: DLTR) is expected to report quarterly earnings at $1.23 per share on revenue of $5.56 billion.
    Express, Inc. (NYSE: EXPR) is projected to report quarterly loss at $0.02 per share on revenue of $466.25 million.
    Dollar General Corporation (NYSE: DG) is estimated to report quarterly earnings at $1.4 per share on revenue of $6.20 billion.
    Tech Data Corporation (NASDAQ: TECD) is expected to report quarterly earnings at $1.46 per share on revenue of $8.13 billion.
    Burlington Stores, Inc. (NYSE: BURL) is estimated to report quarterly earnings at $1.09 per share on revenue of $1.49 billion.
    Ciena Corporation (NYSE: CIEN) is projected to report quarterly earnings at $0.3 per share on revenue of $726.56 million.
    American Eagle Outfitters, Inc. (NYSE: AEO) is expected to report quarterly earnings at $0.22 per share on revenue of $806.17 million.
    Titan Machinery Inc. (NASDAQ: TITN) is estimated to report quarterly loss at $0.08 per share on revenue of $276.27 bmillion.
    Donaldson Company, Inc. (NYSE: DCI) is projected to post quarterly earnings at $0.52 per share on revenue of $682.68 million.
    Ship Finance International Limited (NYSE: SFL) is expected to report quarterly earnings at $0.21 per share on revenue of $92.08 million.
    Perry Ellis International, Inc. (NASDAQ: PERY) is projected to report quarterly earnings at $0.67 per share on revenue of $232.30 million.
    Kirkland's, Inc. (NASDAQ: KIRK) is estimated to report quarterly loss at $0.09 per share on revenue of $140.83 million.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) is expected to report quarterly earnings at $0.18 per share on revenue of $90.20 million.
    J.Jill, Inc. (NYSE: JILL) is projected to report quarterly earnings at $0.19 per share on revenue of $160.50 million.
    Christopher & Banks Corporation (NYSE: CBK) is expected to report quarterly loss at $0.08 per share on revenue of $89.35 million.
  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Joseph Griffin]

    News coverage about Build-A-Bear Workshop (NYSE:BBW) has been trending somewhat negative on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Build-A-Bear Workshop earned a media sentiment score of -0.07 on Accern’s scale. Accern also assigned media stories about the specialty retailer an impact score of 43.9525750448852 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Performing Stocks To Buy For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

Top 10 Performing Stocks To Buy For 2019: Rite Aid Corporation(RAD)

Advisors’ Opinion:

  • [By Max Byerly]

    Rite Aid Co. (NYSE:RAD) dropped 6% during trading on Wednesday . The company traded as low as $1.88 and last traded at $1.89. Approximately 11,889,301 shares traded hands during trading, a decline of 37% from the average daily volume of 18,730,842 shares. The stock had previously closed at $2.01.

  • [By Keith Speights]

    Shares of major pharmacy chains CVS Health Corp. (NYSE:CVS), Rite Aid Corporation (NYSE:RAD), and Walgreens Boots Alliance Inc. (NASDAQ:WBA) sank by 9% or more as of 11:07 a.m. EDT on Thursday. All three stocks were impacted by the same big news: Amazon’s (NASDAQ:AMZN) acquisition of PillPack.

  • [By Max Byerly]

    Glen Harbor Capital Management LLC purchased a new position in shares of Rite Aid Co. (NYSE:RAD) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 220,096 shares of the company’s stock, valued at approximately $370,000.

Top 10 Performing Stocks To Buy For 2019: Bank of Nova Scotia (BNS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) has earned an average rating of “Hold” from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $94.00.

  • [By Shane Hupp]

    Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is C$88.62.

  • [By Motley Fool Staff]

    Bank of Nova Scotia (NYSE:BNS)Q2 2018 Earnings Conference CallMay 29, 2018, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Adam Borgatti — Vice President, Investor Relations

  • [By Stephan Byrd]

    Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) insider Andrew Branion sold 332 shares of the firm’s stock in a transaction on Wednesday, October 10th. The shares were sold at an average price of C$74.49, for a total value of C$24,730.68.